Literature DB >> 10915824

Noradrenergic neurons expressing substance P receptor (NK1) in the locus coeruleus complex: a double immunofluorescence study in the rat.

L W Chen1, L C Wei, H L Liu, Z R Rao.   

Abstract

By using a double immunofluorescence method we examined the distribution of noradrenergic neurons expressing substance P receptor (NK1) or neuromedin K receptor (NK3) in the rat brainstem. The distribution of SPR-like immunoreactive (-LI) neurons completely overlapped that of tyrosine hydroxylase (TH)-LI neurons in the locus coeruleus (A6), ventrolateral and lateral reticular formation of pons (A5 and A7). Partially overlapping distribution of SPR- and TH-LI neurons were found in certain regions of the medulla oblongata (A1-A4). Neurons showing both SPR- and TH-like immunoreactivities, however, were only found in the locus coeruleus complex (A5-A7): 100% of these TH-LI neurons displayed SPR-like immunoreactivity. Neurons showing both NKR- and TH-like immunoreactivities were not detected in the aforementioned areas of brainstem. The present study has provided morphological evidence for direct physiological modulation of noradrenergic neurons by tachykinins through SPR in locus coeruleus complex (A5-A7).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915824     DOI: 10.1016/s0006-8993(00)02494-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

Review 1.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Central chemoreception is a complex system function that involves multiple brain stem sites.

Authors:  Eugene Nattie; Aihua Li
Journal:  J Appl Physiol (1985)       Date:  2008-05-08

3.  Activation of NK₁ receptors in the locus coeruleus induces analgesia through noradrenergic-mediated descending inhibition in a rat model of neuropathic pain.

Authors:  Y Muto; A Sakai; A Sakamoto; H Suzuki
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

4.  Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking.

Authors:  J R Schank; B S Nelson; R Damadzic; J D Tapocik; M Yao; C E King; K E Rowe; K Cheng; K C Rice; M Heilig
Journal:  Neuropharmacology       Date:  2015-07-15       Impact factor: 5.250

5.  Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward.

Authors:  Padmanabhan Mannangatti; Santhanalakshmi Sundaramurthy; Sammanda Ramamoorthy; Lankupalle D Jayanthi
Journal:  Psychopharmacology (Berl)       Date:  2016-12-24       Impact factor: 4.530

6.  Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release.

Authors:  Karl Ebner; Nicolas Singewald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-19       Impact factor: 3.000

Review 7.  Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.

Authors:  Jesse R Schank; Andrey E Ryabinin; William J Giardino; Roberto Ciccocioppo; Markus Heilig
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

8.  Medullary serotonergic neurones and adjacent neurones that express neurokinin-1 receptors are both involved in chemoreception in vivo.

Authors:  Eugene E Nattie; Aihua Li; George B Richerson; George Richerson; Douglas A Lappi
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

9.  Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse.

Authors:  Christopher A Gadd; Patricia Murtra; Carmen De Felipe; Stephen P Hunt
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

10.  Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response.

Authors:  Pierre Blier; Gabriella Gobbi; Nasser Haddjeri; Luca Santarelli; Gina Mathew; René Hen
Journal:  J Psychiatry Neurosci       Date:  2004-05       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.